SA
Create Free Alerts
Spyre Therapeutics, Inc.SYRENASDAQ
Loading
OverviewIntelligenceCharts
Debt Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year debt growth rate

Latest
0.00%
↓ 100% vs avg
Percentile
P33
Within normal range
Average
13.25%
Historical baseline
PeriodValue
Q4 20250.00%
Q3 20250.00%
Q2 20250.00%
Q1 20250.00%
Q4 20240.00%
Q3 20240.00%
Q2 20240.00%
Q1 20240.00%
Q4 20230.00%
Q3 2023-100.00%
Q2 2023-2.26%
Q1 2023-4.28%
Q4 2022-2.47%
Q3 2022-0.98%
Q2 2022-2.66%
Q1 2022-2.69%
Q4 2021-1.96%
Q3 2021-2.48%
Q2 2021-0.60%
Q1 2021-2.28%
Q4 20203.03%
Q3 20207.41%
Q2 2020-3.62%
Q1 20200.89%
Q4 2019-1.80%
Q3 20190.25%
Q2 2019646.44%
Q1 20190.00%
Q4 20180.00%
Q3 20180.00%
Q2 20180.00%
Q1 20180.00%
Q4 20170.00%
Q3 20170.00%
Q2 20170.00%
Q1 20170.00%
Q4 20160.00%
Q3 20160.00%
Q2 20160.00%
Q1 20160.00%

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance